Citation Impact
Citing Papers
Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism
2009
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series
2016
Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor–Mediated Podocyte β3-integrin Activation
2015
Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children
1999
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Recurrence of primary disease in children after renal transplantation: An evidence‐based update
2004
Plasmapheresis for Recurrent Posttransplant Focal Segmental Glomerulosclerosis
2006
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Stressed podocytes—mechanical forces, sensors, signaling and response
2017
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
C5b-9 increases albumin permeability of isolated glomeruli in vitro
1994
Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation
2017
Childhood obesity: public-health crisis, common sense cure
2002 Standout
Pathophysiology of Obesity-Related Renal Dysfunction Contributes to Diabetic Nephropathy
2012
Renal albumin absorption in physiology and pathology
2006
Renal handling of albumin: A critical review of basic concepts and perspective
2002
Recurrent disease in renal transplants
2003
Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: Re‐analysis of published case‐reports and case‐series
2001
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Chronic kidney disease
2011 Standout
Therapeutic Apheresis for Renal Disorders
2012
Induction of T Regulatory Cells Attenuates Idiopathic Nephrotic Syndrome
2008 Standout
Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game?
1997
Piezos thrive under pressure: mechanically activated ion channels in health and disease
2017 StandoutNobel
Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome
2006
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
RECURRENT GLOMERULONEPHRITIS FOLLOWING RENAL TRANSPLANTATION
1997
Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: A single center experience
2008
Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study
2009
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
2007 Standout
Plasmapheresis Therapy in Renal Transplant Patients: Five-Year Experience
2011
Regulation of podocyte structure during the development of nephrotic syndrome
1998
Therapeutic apheresis in renal and metabolic diseases
2000
Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis
2003
Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients
2005
Apheresis in Cryoglobulinemia Complicating Hepatitis C and in Other Renal Diseases
2002
Recurrent Glomerulonephritis After Kidney Transplantation
2006
Therapeutic Apheresis Rescue Mission: Recurrent Focal Segmental Glomerulosclerosis in Renal Allografts
2011
Myeloperoxidase in kidney disease
2003
Glomerular Overproduction of Oxygen Radicals in Mpv17 Gene-Inactivated Mice Causes Podocyte Foot Process Flattening and Proteinuria
1999
The Urinary Podocyte as a Marker for the Differential Diagnosis of Idiopathic Focal Glomerulosclerosis and Minimal-Change Nephrotic Syndrome
2000
Regulation of mouse podocyte process dynamics by protein tyrosine phosphatases
2000
Oxidative stress in chronic kidney disease
2018 Standout
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
The Nephrotic Syndrome
1998
Long‐term effect of rituximab in maintaining remission of recurrent and plasmapheresis‐dependent nephrotic syndrome post‐renal transplantation – Case report
2010
A primer on recurrent and de novo glomerulonephritis in renal allografts
2008
Effects of anti-TGF-β type II receptor antibody on experimental glomerulonephritis
2001
Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents
2001
Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient
2010
Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy
1998
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Nitric Oxide Increases Albumin Permeability of Isolated Rat Glomeruli via a Phosphorylation-Dependent Mechanism
2001
Recurrent Glomerulonephritis after Renal Transplantation
2008
Phenotypic Characteristics and Cyclin-Dependent Kinase Inhibitors Repression in Hyperplastic Epithelial Pathology in Idiopathic Focal Segmental Glomerulosclerosis
2000
Apheresis for Renal Disease
2001
Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
2000 Standout
Idiopathic focal segmental glomerulosclerosis
2003
Identifying Specific Causes of Kidney Allograft Loss
2009 Standout
Antimicrobial strategies centered around reactive oxygen species – bactericidal antibiotics, photodynamic therapy, and beyond
2013 Standout
Principles of Separation
2013
Progression of glomerular diseases: Is the podocyte the culprit?
1998
Modifying Normal Tissue Damage Postirradiation
2002
Plasmapheresis for the Prophylaxis and Treatment of Recurrent Focal Segmental Glomerulosclerosis Following Renal Transplant
2005
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Combination Treatment With Plasmapheresis and Rituximab for Recurrent Focal Segmental Glomerulosclerosis After Renal Transplantation
2010
New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis
2005
RECURRENT AND DE NOVO GLOMERULAR DISEASE AFTER RENAL TRANSPLANTATION
1999
Successful Anti-TNFα Treatment in a Child with Posttransplant Recurrent Focal Segmental Glomerulosclerosis
2009
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis
2009
Circulating Permeability Factors in Idiopathic Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
2010
Tumor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphangiogenesis
2002 Standout
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
2011
Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function
2009
Plasmapheresis for the treatment of kidney diseases
2016
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Zinc supplementation partially prevents renal pathological changes in diabetic rats
2009
Mesangial Matrix Modulation and Glomerulosclerosis
1999
Recurrent glomerulonephritis following renal transplantation: an update
2003
Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation
2011
Glomerular hyperfiltration
2022
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
TGF‐β signaling and the fibrotic response
2004 Standout
Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes.
1998
Integrin linked kinase as a candidate downstream effector in proteinuria
2001
Integrins in kidney development, function, and disease
2000
Expression of Functional CCR and CXCR Chemokine Receptors in Podocytes
2002
The effect of peri‐transplant plasmapheresis in the prevention of recurrent FSGS
2018
Overexpression of Cu2+/Zn2+ Superoxide Dismutase Protects Against Early Diabetic Glomerular Injury in Transgenic Mice
2001
Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy
2004
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
Preemptive Plasmapheresis and Recurrence of FSGS in High‐Risk Renal Transplant Recipients
2005
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Interventions for preventing obesity in children
2019 Standout
Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model
2009
Extracorporeal Plasma Treatment in Primary and Recurrent Focal Segmental Glomerular Sclerosis: A Review
2001
Pathobiology of focal segmental glomerulosclerosis
2012
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Protection of α3 integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat
2000
Is the kidney a target of SARS-CoV-2?
2020
Treatment of Pyoderma Gangrenosum with Oral Tripterygium wilfordii Multiglycoside
2000
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
2005
Exploring the connection between chronic renal fibrosis and bone morphogenic protein-7.
2003
Hematological Problems in Pediatric Intensive Care
2013 Standout
Myeloperoxidase: friend and foe
2005 Standout
Treatment of focal segmental glomerulosclerosis
2005
Works of Ram Sharma being referenced
Prostaglandin E2 is crucial in the response of podocytes to fluid flow shear stress
2010
CYCLOSPORINE PROTECTS GLOMERULI FROM FSGS FACTOR VIA AN INCREASE IN GLOMERULAR cAMP1,2
1996
“The FSGS Factor”
1999
Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental Glomerulosclerosis
1996
Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells
2001
CYCLOSPORINE PREVENTS THE INCREASE IN GLOMERULAR ALBUMIN PERMEABILITY CAUSED BY SERUM FROM PATIENTS WITH FOCAL SEGMENTAL GLOMERULAR SCLEROSIS
1996
Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor
2018
ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide
2009
Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro
1997
Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes
2006
Plasmapheresis Reduces Proteinuria and Serum Capacity to Injure Glomeruli in Patients With Recurrent Focal Glomerulosclerosis
1994
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier
2004
Serial Estimates of Serum Permeability Activity and Clinical Correlates in Patients with Native Kidney Focal Segmental Glomerulosclerosis
2003
Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid
1994
Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (Palb)
2009
Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity
2008
Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli
2004
Transforming growth factor-β1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals
2000
Direct Effects of Platelet-Activating Factor on Glomerular Capillary Permeability
1997
Early Detection of Radiation-Induced Glomerular Injury by Albumin Permeability Assay
2001
Matrix metalloproteinase (stromelysin-1) increases the albumin permeability of isolated rat glomeruli
1996
Chymase increases glomerular albumin permeability via protease-activated receptor-2
2006
Fluid flow shear stress upregulates prostanoid receptor EP2 but not EP4 in murine podocytes
2012
Fluid flow shear stress over podocytes is increased in the solitary kidney
2013
PROTEINURIA AFTER INJECTION OF HUMAN FOCAL SEGMENTAL GLOMERULOSCLEROSIS FACTOR12
2002
Molecular basis of protective effect by crocetin on survival and liver tissue damage following hemorrhagic shock
2005
Effect of superoxide exposure on albumin permeability of isolated rat glomeruli.
1993
Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney
2014
Induction of Metallothionein-I Protects Glomeruli from Superoxide-Mediated Increase in Albumin Permeability
2002
Alteration of glomerular permeability to macromolecules induced by cross-linking of beta 1 integrin receptors.
1996
Mechanotransduction signaling in podocytes from fluid flow shear stress
2017
The Focal Segmental Glomerulosclerosis Permeability Factor: Biochemical Characteristics and Biological Effects
2004